@entity14 ( @entity14 ) is the major cause of @entity204 in @entity1 diagnosed with @entity14 . The gold standard treatment of @entity14 is surgical resection. Yet, in the past, more than half of these @entity1 were deemed unresectable due to the inadequate future liver remnant (FLR). The introduction of efficient portal vein embolization (PVE) preoperatively allowed more resections of @entity3 in @entity14 @entity1 by stimulating adequate liver @entity1184 . However, several experimental and clinical studies reported @entity5 progression after PVE which critically influences the subsequent management of these @entity1 . The underlying pathophysiological mechanism of @entity5 progression post-PVE is still not fully understood. In spite of the adverse effects of PVE, it remains a potentially curative procedure in @entity1 who would remain otherwise unresectable because of the insufficient FLR. Currently, the challenge is to halt @entity5 proliferation following PVE in @entity1 who require this technique. This could potentially be achieved by either attempting to suppress the underlying oncologic stimulus or by inhibiting @entity5 growth once observed after PVE, without jeopardizing @entity409 . More research is still required to better identify @entity1 at risk of experiencing @entity5 growth post-PVE.

Portal vein embolization effect on XXXX liver @entity3 progression: Lessons learned.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1184 :: ('MESH:D006984', 'Disease') :: ['hypertrophy'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver regeneration'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity14 :: ('MESH:D015179', 'Disease') :: ['CRLM', 'Colorectal liver metastasis', 'colorectal cancer'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity14 :: (MESH:D015179,Disease) :: ['colorectal cancer']
